Article

Combination of Circulating Cell-Free DNA and Metabolic Tumor Burden to Distinguish Non-Small Cell Lung Cancer from Tuberculosis

2021-09-07

Abstract excerpt

<h4>Background: </h4> Non-small cell lung (NSCLC) holds high mortality owing to the difficulty to early detection from other lung mass, such as tuberculosis. This study evaluates the clinical value of the combination of circulating cell-free DNA (cfDNA) quantification and metabolic tumor burden to distinguish NSCLC from tuberculosis. <h4>Methods: </h4>: A total of 149 NSCLC patients, 151 tuberculosis patients and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c2f38f22-c211-534e-b69f-69bce7ccee2d
DOI: 10.21203/rs.3.rs-54830/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Combination of Circulating Cell-Free DNA and Metabolic Tumor Burden to Distinguish Non-Small Cell Lung Cancer from TuberculosisDOI 10.21203/rs.3.rs-54830/v2Read

Plasma cell-free DNA level and its integrity as biomarkers to distinguish non-small cell lung cancer from tuberculosisSemantic proximity Read

A potential link between tuberculosis and lung cancer through non-coding RNAsSemantic proximity Read

Application of Circulating Genetically Abnormal Cells in the Early-stage Diagnosis of Lung CancerSemantic proximity Read

Integrative and Comparative Genomic Analysis and the Immune Microenvironment Features of Lung Cancer Patients with TuberculosisSemantic proximity Read

Radiomicsmetabolic signature profiles for advanced non-small cell lung cancer with chemoimmunotherapy by reflecting biological function and survivalSemantic proximity Read

Clinical characteristics and survival of patients concurrently diagnosed with lung cancer and active pulmonary tuberculosisSemantic proximity Read

Identification of differential expressed PE exosomal miRNA in lung adenocarcinoma, tuberculosis, and other benign lesionsSemantic proximity Read

Quantification of circulating cell-free DNA to predict patient survival in non-small-cell lung cancerSemantic proximity Read

Identification of MicroRNAs as Potential Blood-Based Biomarkers for Diagnosis and Therapeutic Monitoring of Active TuberculosisSemantic proximity Read

Omics analysis revealed the antitumor effect of mitochondrial targeted drug combinationSemantic proximity Read

The Value of CT Radiomics Analysis of Cavity Characteristics In Differentiating Nontuberculous Mycobacteriumpulmonary Disease From Pulmonary TuberculosisSemantic proximity Read

[Analysis of Clinical Characteristics and Driver Genes in 405 Patients with Lung Cancer Complicated with Tuberculosis].Semantic proximity Read